Artemis Investment Management LLP Pfizer Inc Transaction History

Artemis Investment Management LLP

$6.19 Billion
Q1 2025

A detailed history of Artemis Investment Management LLP transactions in Pfizer Inc stock. As of the latest transaction made, Artemis Investment Management LLP holds 584,206 shares of PFE stock, worth $13.7 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

584,206

Previous 448,076 30.38%

Holding current value

$13.7 Million

Previous $11.9 Million 24.53%

% of portfolio

0.24%

Previous 0.18%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	BUY	$25.01 - $27.13 $3.4 Million - $3.69 Million	136,130 Added 30.38%	584,206 $14.8 Million
Q4 2024 Jan 16, 2025	SELL	$24.8 - $30.19 $298,864 - $363,819	-12,051 Reduced 2.62%	448,076 $11.9 Million
Q3 2024 Oct 08, 2024	BUY	$27.7 - $31.39 $2.78 Million - $3.15 Million	100,492 Added 27.94%	460,127 $13.3 Million
Q2 2024 Jul 15, 2024	BUY	$25.26 - $29.6 $9.08 Million - $10.6 Million	359,635 New	359,635 $10.1 Million
Q4 2022 Jan 25, 2023	SELL	$41.75 - $54.5 $25.1 Million - $32.8 Million	-602,070 Reduced 20.93%	2,274,408 $0
Q3 2022 Oct 25, 2022	BUY	$43.76 - $53.42 $8.88 Million - $10.8 Million	202,992 Added 7.59%	2,876,478 $126 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $58.6 Million - $69.5 Million	-1,258,863 Reduced 32.01%	2,673,486 $141 Million
Q1 2022 Apr 21, 2022	SELL	$45.75 - $56.69 $35.4 Million - $43.8 Million	-772,995 Reduced 16.43%	3,932,349 $203 Million
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $9.36 Million - $13.9 Million	-226,543 Reduced 4.59%	4,705,344 $278 Million
Q3 2021 Oct 26, 2021	BUY	$39.25 - $50.42 $181 Million - $233 Million	4,615,310 Added 1457.88%	4,931,887 $212 Million
Q2 2021 Aug 04, 2021	SELL	$35.91 - $40.68 $15.3 Million - $17.3 Million	-425,246 Reduced 57.32%	316,577 $12.4 Million
Q1 2021 Apr 28, 2021	BUY	$33.49 - $37.77 $6.96 Million - $7.85 Million	207,837 Added 38.92%	741,823 $26.9 Million
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $1.44 Million - $1.84 Million	43,172 Added 8.8%	533,986 $19.7 Million
Q3 2020 Oct 29, 2020	SELL	$31.75 - $37.25 $659,003 - $773,161	-20,756 Reduced 4.06%	490,814 $18 Million
Q2 2020 Jul 27, 2020	SELL	$30.12 - $36.54 $28.3 Million - $34.3 Million	-938,379 Reduced 64.72%	511,570 $16.8 Million
Q1 2020 Apr 14, 2020	BUY	$27.03 - $38.62 $30 Million - $42.8 Million	1,108,745 Added 324.95%	1,449,949 $47.4 Million
Q4 2019 Jan 14, 2020	SELL	$32.92 - $37.36 $17.9 Million - $20.3 Million	-543,254 Reduced 61.42%	341,204 $13.4 Million
Q3 2019 Oct 10, 2019	SELL	$32.49 - $42.13 $57.9 Million - $75.1 Million	-1,782,583 Reduced 66.84%	884,458 $31.7 Million
Q2 2019 Jul 24, 2019	BUY	$36.98 - $41.52 $3.11 Million - $3.49 Million	84,137 Added 3.26%	2,667,041 $115 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $9.07 Million - $9.96 Million	241,857 Added 10.33%	2,582,904 $110 Million
Q4 2018 Feb 12, 2019	BUY	$38.47 - $43.86 $48.2 Million - $55 Million	1,252,889 Added 115.14%	2,341,047 $102 Million
Q3 2018 Nov 09, 2018	BUY	$34.47 - $41.81 $12 Million - $14.6 Million	348,788 Added 47.17%	1,088,158 $48 Million
Q2 2018 Aug 08, 2018	BUY	$32.98 - $35.16 $6.94 Million - $7.4 Million	210,400 Added 39.78%	739,370 $26.8 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $16.2 Million - $18.8 Million	508,000 Added 2422.51%	528,970 $18.8 Million
Q4 2017 Feb 08, 2018	SELL	$33.26 - $35.29 $29 Million - $30.8 Million	-872,412 Reduced 97.65%	20,970 $760,000
Q3 2017 Oct 31, 2017	SELL	$31.0 - $34.15 $11.1 Million - $12.2 Million	-358,462 Reduced 28.63%	893,382 $31.9 Million
Q2 2017 Aug 09, 2017	BUY	N/A	1,251,844	1,251,844 $42.1 Million

Others Institutions Holding PFE

# of Institutions

3,367

Shares Held

3.61B

Call Options Held

102M

Put Options Held

130M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $132B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Investment Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Investment Management LLP with notifications on news.

Account

Artemis Investment Management LLP Pfizer Inc Transaction History